文献速递糖尿病

2型糖尿病患者体重变化后心血管疾病风险:队列研究与荟萃分析

The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2022-08-15

本研究包含队列研究与荟萃分析,评估2型糖尿病患者18个月体重变化与随后大血管及微血管并发症风险的关系。队列研究纳入8920名有有效体重测量值的参与者,按体重变化分为5组,使用Cox回归估计风险比(HR)及95%置信区间(95%CI),并用随机效应模型合并其他相关研究。结果显示,与体重稳定相比,体重变化(尤其≥5%)与总血管并发症、大血管并发症和微血管并发症风险升高相关,荟萃分析结果相似。

要点

  • 18个月内体重变化≥5%(增加或减少)与总血管并发症风险升高相关。
  • 体重变化与微血管并发症风险升高相关,仅见于体重减少≥5%组。
  • 作者认为体重变化≥5%可能是不良心血管结局的警示信号。

核心结论

  • 2型糖尿病患者18个月内体重增加或减少,尤其是体重变化≥5%,可能是不良心血管结局的警示信号。

研究设计与样本

  • 研究由队列研究和荟萃分析组成。
  • 队列研究中,18个月体重变化分为5组:增加≥5%、增加1%-5%、稳定(-1%-1%)、减少1%-5%、减少≥5%。
  • 采用Cox回归分析估计风险比(HR)和95%置信区间(95%CI)。
  • 采用随机效应模型合并本研究与其他相关研究的结果。
  • 队列研究纳入8920名有有效体重测量值的2型糖尿病参与者。

主要发现

  • 与体重稳定者相比,总血管并发症风险升高:体重增加≥5%组HR=1.43(95%CI:1.10-1.85);体重增加1%-5%组HR=1.44(95%CI:1.02-2.03);体重减少≥5%组HR=1.58(95%CI:1.20-2.08)。
  • 与体重稳定者相比,大血管并发症风险升高:体重增加≥5%组HR=1.84(95%CI:1.16-2.91);体重减少1%-5%组HR=1.91(95%CI:1.06-3.43);体重减少≥5%组HR=2.18(95%CI:1.36-3.49)。
  • 与体重稳定者相比,微血管并发症风险升高:体重减少≥5%组HR=1.48(95%CI:1.06-2.06)。
  • 荟萃分析也显示了相似的结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Weight management is recognized as critical in reducing cardio-metabolic risk factors for adults with diabetes, but the effects of weight change on cardiovascular disease in patients with diabetes are unknown. OBJECTIVE: To evaluate 18-month weight change and subsequent risk of macrovascular and microvascular complications in established individuals with type 2 diabetes. DESIGN AND SETTING: This study consisted of a cohort study and a meta-analysis. In the cohort study, weight change over 18 months was divided into: gain ≥5%, gain 1%-5%, stable (-1%-1%), loss 1%-5%, and loss ≥5%. Cox regression analyses were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI). We then used random-effect models to pool the results combing our study with other relevant studies. RESULTS: In the cohort study, 8920 participants with valid weight measurements were included. Compared with patients with stable weight, higher risks were seen in those with weight change for total vascular complications (gain ≥5%: HR=1.43, 95% CI: 1.10-1.85; gain 1-5%: HR=1.44, 95% CI: 1.02-2.03; loss ≥5%: HR=1.58, 95% CI: 1.20-2.08), macrovascular complications (gain ≥5%: HR=1.84, 95% CI: 1.16-2.91; loss 1-5%: HR=1.91, 95% CI: 1.06-3.43; loss ≥5%: HR=2.18, 95% CI: 1.36-3.49) and microvascular complications (loss ≥5%: HR=1.48, 95% CI: 1.06-2.06). Meta-analysis also showed similar results. CONCLUSIONS: Weight gain and loss over 18 months among patients with type 2 diabetes, especially weight change ≥5%, may be a warning sign of adverse cardiovascular outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Dong Y, Chen Z, Gong Y, et al. The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis. J Clin Endocrinol Metab. 2022. PMID: 35965478. doi:10.1210/clinem/dgac485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。